ReviewMedical sciences (Basel, Switzerland)2023

Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel-Lindau-Disease-Associated Tumors.

Cristina Suárez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.